Mesalamine Suspension
Product Images NDC 21922-045

9 FDA label images from Encube Ethicals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 21922-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Encube Ethicals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Str)

Str (Str)
Chemical structure of Mesalamine showing a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*
FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
A black-and-white instructional illustration showing hands opening a sealed pouch by grasping the seam and tearing it down the middle. The image demonstrates the proper way to open the packaging, likely for a medication or product enclosed within.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
An instructional illustration showing two hands holding medical devices. The left hand holds a syringe-like applicator, and the right hand holds a nozzle with a ring finger grip, likely indicating steps for preparing or using a rectal suspension medication device.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
Illustration showing a person lying on their left side with the right knee bent and right arm positioned for support. This depiction is commonly used to demonstrate the recommended position for rectal administration of medication.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
An anatomical illustration showing a person positioned on hands and knees with their chest lowered toward the floor. The figure is depicted preparing for a rectal administration procedure, likely related to the use of mesalamine rectal suspension.*
FDA Label Image

Image-05 (Image 05)

Image-05 (Image 05)
An instructional illustration showing one hand holding a suspension bottle while the other hand removes or attaches the cap.*
FDA Label Image

Carton-7 (Carton 7)

Carton-7 (Carton   7)
Mesalamine Rectal Suspension, USP Enema 4 g/60 mL packaging label from Encube Ethicals, Inc. This box contains 7 unit-dose bottles of 60 mL each. The label includes usage instructions stating for rectal use only and to shake well before using. The product is prescription only (Rx Only) and dispensed as a kit in its existing packaging, not to be repackaged. Additional details mention storage conditions, potential for product discoloration, and manufacturer/distributor information.*
FDA Label Image

Carton-28 (Carton 28)

Carton-28 (Carton   28)
Mesalamine Rectal Suspension, USP Enema 4 g/60 mL packaging label from Encube Ethicals, Inc. The label displays the product as a rectal suspension for prescription use only, in 28 x 60 mL unit-dose bottles (28 pack). Instructions include shaking well before use and dispensing as a single unit without repackaging. The label features the kit designation and standard warnings about use and storage.*
FDA Label Image

Cnt-label (Container)

Cnt-label (Container)
Label for Mesalamine Rectal Suspension, USP Enema, 4 g/60 mL, a rectal suspension product by Encube Ethicals, Inc. The label states the product is for rectal use only, comes in a 60 mL unit-dose container, and is Rx only. It includes storage instructions, manufacturer and distributor details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.